Market Insight

Markets rarely move at random. InvestorPlace’s leading analysts break down macro trends, sector dynamics, and recurring market patterns to help investors understand what is changing, what matters most, and where opportunities may emerge.

Microsoft Corporation Earnings: Mr. Softee Becomes Mr. Cloud

MSFT is rallying after a clear earnings beat as analysts digested Microsoft's slower-than-expected growth in cloud revenue.

Despite Earnings Beat, Oil Price Cycles Drive ConocoPhillips Stock

COP stock could prove a challenge as the cyclical nature of COP could make holding gains a challenge for owners of ConocoPhillips stock.

No Point Digging for Profits in Newmont Mining Corp Stock

Newmont Mining stock has seen little movement for decades as NEM trades as a proxy for gold prices, limiting the profit potential of NEM stock.

4 Earnings Losers from Thursday’s Trading

We're in the thick of earnings seasons and while a lot of stocks are rallying on their earnings results, these 4 earnings losers haven't been as fortunate.

Despite Surviving Short Attack, Herbalife Ltd. Stock Is Still Overvalued

While Herbalife seems to shrug off every piece of bad news, HLF stock is overvalued and still carries significant risks.

Target Corporation Stock Holding Up Well Despite Amazon’s Domination

Target has been doing pretty well this year, with its stock up about 10%. As long as TGT stock stays above $68, bulls can stay long.

Don’t Bet Too Heavily on Alibaba Group Holding Ltd

Several analysts are bullish on BABA stock heading into its Q4 earnings report, but some of the details don’t add up, including questionable projected growth in China's middle class. Given how many holes there are in Alibaba stock, investors would be wise to not bet too heavily on BABA.

Investors Are Selling Into Earnings Strength

Nobody seems to be questioning the idea that the first quarter was a solid one. However, confidence that the coming quarters are going to be just as strong seems to be slipping a bit.

As Prices Heat Up, Don’t Overlook Bitcoin Investment Trust

With the bitcoin price possibly set for a recovery rally, now may be a good time to consider “pure” cryptocurrency stocks.

Boston Beer Company Inc Is Looking Beyond Beer With New Products

Boston Beer Company's management team has kept SAM's beer production lean and started producing cider and other nontraditional beverages.

Some Pro Perspective on This Bond Market Volatility

The falling bond market and rising interest rates are a poor reason for investors to panic in and of themselves.

Despite Big Gains, Major Questions Remain for Samsung Electronics Co Ltd Stock

You can buy SSNLF stock for Samsung's persistent growth in the face of intense competition, or sell Samsung for its own missteps and fear of Chinese competition.

10 Cutting-Edge Stocks for Your Portfolio

These 10 stocks all have cutting edge technology or capabilities - and valuations that don't fully price in their advantages.

UnitedHealth Group Inc Looks Like It May Be Unstoppable

UnitedHealth stock posted stellar first-quarter results. UNH may not be a buy immediately after its post-earnings pop but it's tough to see anything slowing the health insurer down. Investors should add UNH stock to their watchlists if they don't own it already.

Overvalued Starbucks Corporation Stock Will Stay Stuck in Neutral

SBUX stock hasn't done anything for the past several years, and the company's slowing growth prospects imply that this stock won't do anything for the next several years, too.

AMC Entertainment Holdings Inc Stock Will Soar on Summer Blockbusters

Fears related to the death of movie theaters have been greatly exaggerated, leaving AMC stock materially undervalued at current levels. 

Twitter Stock Whipsaws After Big Earnings Beat — Should You Buy?

Twitter stock jumped bigtime in pre-market trading after a strong Q1 earnings beat, but subscriber growth will be a talking point for TWTR bulls going forward.

From Test Tube to the Drugstore: The Drug Development Process

The medications and drugs you see in your bathroom medicine cabinet and in your local pharmacy have taken a long journey to get there, from their initial origins in the laboratory to approval by the U.S. Food & Drug Administration (FDA), and finally, marketing to consumers. This article, the first in a series, will describe the processes of drug discovery, drug development and pre-clinical research.

Eli Lilly And Co Produced a Monstrous Q1 Beat, But Is It Enough?

LLY stock delivered outstanding results for its just released Q1 report, but significant questions about its future direction remain.